Is Iovance Biotherapeutics Stock a Millionaire Maker?

The biotech industry has been described as the Wild West of the stock market. Although some companies manage to develop and commercialize a life-changing therapeutic, countless more start-ups inevitably fail. Nevertheless, the risk could be worth the reward if a new blockbuster drug creates massive shareholder wealth.While that level of success is only obvious in hindsight, Iovance Biotherapeutics (NASDAQ: IOVA) is an emerging industry leader with significant potential. The company's tumor-infiltrating lymphocyte (TIL) therapy is seen as a revolutionary treatment for a wide range of cancers, highlighting the attractiveness of the stock.Could buying shares of Iovance make you a millionaire? Here's what you need to know.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool